While the legalization of recreational cannabis remains a contentious issue across the globe, medical marijuana innovators continue to push the envelope with groundbreaking treatments for a variety of ailments and conditions, from novel cancer treatments to more effective seizure management medications.
And with VC firms like Canopy, Poseidon, and Tuatara Capital getting in on the funding action, you can expect to more innovative medical and health-related cannabis tech startups on the horizon. The following are the top 11 cannatech healthcare and medical startups you need to be aware of in 2017 and beyond.
Cannabinoids (CBD) are non-psychoactive, key compounds in marijuana proven to have a myriad of health benefits, from combating tumors and cancer cells to controlling seizures. Hyasynth Bio specializes in CBD development—amazingly, its platform can create cannabinoids using engineered yeast.
PotBotics aims to make cannabis medicine easier to understand and use for patients. Its PotBot app—backed by medical and scientific data—recommends the proper marijuana strains to users based on symptoms, body effects, and even data from EEG brain scans.
Ehave is a mental healthcare startup developing digital solutions to further advance applications in medical marijuana. The company’s mental health informatics platform tracks medical cannabis patients and their treatment plans for efficacy, ultimately resulting in better treatment guidelines for cannabis therapies.
Medical marijuana innovators wishing to protect their intellectual property (IP) have a new weapon in their arsenal. Using blockchain technology, Medicinal Genomics is able to offer growers some degree of IP protection by registering their cannabis strain DNA sequences on the public ledger.
Like Hyacynth Bio, Vitality Biopharma is focused on developing medical treatments using CBDs—specifically, to address neurological and inflammatory conditions. The company has developed a proprietary platform for identifying new CBD pharmaceutical drug candidates.
Syqe Medical develops selective dose, pharmaceutical-grade medical plant inhalers for medical marijuana users. Its two main products—the Syqe Inhaler and Syqe Inhaler Exo—use pre-loaded cartridges to deliver cannabis medicine in incremental, 100 microgram doses.
Steep Hill provides medical cannabis data analytics and testing services to ensure that medications in question comply with public safety standards. Its QuantaCann platform analyzes and tests marijuana strains in a matter of minutes, providing information such as THC/cannabidiol potency levels, moisture content, and more.
Confident Cannabis develops software applications for viewing and sharing medical cannabis testing results, with the goal of improving transparency in the cannabis industry. The company is also building an expansive, real-time database of cannabis products sold in U.S. medical marijuana dispensaries.
Cannabics Pharmaceuticals has developed a delayed-release cannabis pill for improving the life quality of advanced stage cancer patients. The company also uses advanced screening and bioinformatics tools for creating natural therapies custom-tailored for each unique patient.
PalliaTech was the first to develop and patent a medical cannabis vaporizer capable of delivering single, metered doses of medication. The company has since evolved into a biotech firm focused on developing innovative cannabis and CBD-based medicines.
One World Cannabis (OWC) specializes in the research and development of cannabis-based therapies, treatments, and medical products for illnesses/conditions: multiple myeloma, psoriasis, fibromyalgia, migraines, PTSD, and more. For example, the company offers a cannabis medication in tablet form to treat pain, as well as a topical cream for treating psoriasis and other skin diseases.
According to leading market research firm ArcView, legal cannabis revenues in the U.S. will reach $21.8 billion by 2020, with $10.2 billion attributed to medical marijuana-related sales. Be sure to keep your eye on this burgeoning space—and these 11 cannatech startups—on your radar in 2017 and beyond.